UFP Technologies, Inc. (UFPT)

UFP Technologies' stock price has shown mixed performance over the past six months. Its share price outperformed the S&P500 Index by 1.96% but was trading 14.89% below its 200-day moving average. Between April 7, 2025, and April 2, 2026, the share price experienced a decline of 2.52%. Investor sentiment reportedly improved in January, leading to a 15% rise in the stock. In its Q3 2025 results, the company reported sales growth of 6.5%, with MedTech sales increasing by 7.3%. Strong operating results were partially offset by approximately $3 million in incremental labor costs at its Illinois AJR facility, which impacted earnings per share.

UFP Technologies has demonstrated consistent and growing demand, particularly within its MedTech business. The company's strategic pivot towards medical end-markets has driven double-digit revenue growth. Demand is centered on minimally invasive devices, implantable-grade components, and precision packaging, with management planning cleanroom expansions to meet growing MedTech demand. The company's focus on the medical sector suggests a stable and expanding demand driven by ongoing medical procedures and technological advancements rather than significant seasonality.

UFP Technologies, Inc. (UFPT) designs and manufactures comprehensive solutions, primarily focusing on medical devices, sterile packaging, and other highly engineered custom products. The company operates within the Medical Equipment, Supplies & Distribution sector, also categorized under Health Care Products Manufacturing and Industrial Specialties. Its major products include a wide range of single-use and single-patient medical devices, components, and packaging for various applications. Beyond the medical market, UFP Technologies also provides engineered products and components for other sectors.

UFP Technologies has a significant manufacturing presence across North America, with facilities in the United States, Mexico, and Canada. The company has expanded its international footprint to include locations in Ireland, Costa Rica, the Dominican Republic, and Singapore, supporting a global customer base, particularly within the medical device industry.

UFP Technologies has received recognition for its workplace environment, being named one of the "Best and Brightest Companies to Work for In The Nation" for multiple consecutive years, including 2024, 2023, and 2022. There have been no specific events reported in the past year that negatively impacted the company's brand reputation.

UFP Technologies' ownership is predominantly held by institutional investors and hedge funds, which collectively owned 87.28% of the company's stock as of August 19, 2025. Key institutional shareholders include BlackRock, Inc., Wasatch Advisors Inc, Vanguard Group Inc, Congress Asset Management Co /ma, Neuberger Berman Group LLC, State Street Corp, American Century Companies Inc, Thrivent Financial For Lutherans, Boston Trust Walden Corp, and UBS Group AG. Insider ownership constitutes a smaller portion, reported as 3.73% as of August 21, 2025.